Clinical Trial Update: A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia [Phase 2]

View source ↗

Summary

The trial to evaluate the safety of vosoritide in at-risk infants with achondroplasia remains active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• Vosoritide (vosoritide)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Achondroplasia | Phase 2 | Status: ACTIVE_NOT_RECRUITING